https://www.selleckchem.com/pr....oducts/mcc950-sodium
Multiple myeloma (MM) is a treatable plasma cell cancer with no cure. Clinical evidence shows that the status of minimal residual disease (MRD) after treatment is an independent prognostic factor of MM. MRD indicates the depth of post-therapeutic remission. In this review article, we outlined the major clinical trials that have determined the prognostic value of MRD in MM. We also reviewed different methods that were used for MM MRD assessment. link2 Most important, we reviewed our current understanding of MM MRD biology. MRD
Like
Comment
Share
